Vasotec Related Published Studies
Well-designed clinical trials related to Vasotec (Enalapril)
Renal and retinal effects of enalapril and losartan in type 1 diabetes. [2009.07.02]
Effects of enalapril or nifedipine on muscle strength or functional capacity in elderly subjects. A double blind trial. [2009.06]
Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker. [2009.04]
Efficacy of exercise, losartan, enalapril, atenolol and rilmenidine in subjects with blood pressure hyperreactivity at treadmill stress test and left ventricular hypertrophy. [2009.04]
Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril. [2009.03]
Myocardial protection with enalaprilat in patients unresponsive to ischemic preconditioning during percutaneous coronary intervention. [2008.12]
Comparison of the effects of candesartan cilexetil and enalapril maleate on right ventricular myocardial remodeling in dogs with experimentally induced pulmonary stenosis. [2008.12]
[The effect of baseline homocysteine level on the efficacy of enalapril maleate and folic acid tablet in lowering blood pressure and plasma homocysteine] [2008.11.18]
Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: A multicenter, randomized, double-blind, parallel-controlled, clinical trial. [2008.11]
Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide. [2008.10]
Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial. [2008.10]
Long-term effect of a chicken-based diet versus enalapril on albuminuria in type 2 diabetic patients with microalbuminuria. [2008.09]
Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: A multicenter, randomized, double-blind, parallel-controlled, clinical trial. [2008.07.23]
Combination therapy with amiodarone and enalapril in patients with paroxysmal atrial fibrillation prevents the development of structural atrial remodeling. [2008.07]
Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic Peptide in patients with chronic heart failure. [2008.05]
The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. [2008.03]
Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms. [2008.02]
Cost analysis of amlodipine versus enalapril in patients with coronary artery disease and normal blood pressure: findings from the CAMELOT economic substudy. [2008]
Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. [2007.10.01]
An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension. [2007.10]
The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog. [2007.10]
Renin-angiotensin system polymorphisms and hemoglobin level in renal allografts: a comparative study between losartan and enalapril. [2007.05]
Pretreatment with intracoronary enalaprilat protects human myocardium during percutaneous coronary angioplasty. [2007.04.17]
Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial. [2007.03]
Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition. [2007.02]
Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes. [2007.01]
Efficacy and tolerability of trandolapril in mild to moderate hypertension--a double blind comparative clinical trial with enalapril in Indian population. [2006.10]
Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes. [2006.08]
Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients. [2006.07]
Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study. [2006.06]
Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure. [2006.05]
Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial. [2006.04]
Prevalence and prognostic significance of anemia in patients with congestive heart failure treated with standard vs high doses of enalapril. [2006.03]
[Head-to-head comparison of clinical, biochemical and functional effects of fosinopril and enalapril in patients with systolic heart failure] [2006.01]
Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension. [2006.01]
Efficacy and safety of 24 weeks of therapy with bendroflumethiazide 1.25 mg/day or 2.5 mg/day and potassium chloride compared with enalapril 10 mg/day and amlodipine 5 mg/day in patients with mild to moderate primary hypertension : a multicentre, randomised, open study. [2006]
Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. [2005.11]
Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. [2005.10.18]
Enalapril suppresses ventricular remodeling more effectively than losartan in patients with acute myocardial infarction. [2005.10]
Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both. [2005.09.01]
Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitation. [2005.09]
[Double blind study of the efficacy and safety of the fixed dose combination of enalapril 10 mg/nitrendipine 20 mg versus the increase of amlopidine dose in essential hypertensive patients not controlled with amlodipine 5 mg] [2005.09]
Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study. [2005.08]
Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function. [2005.08]
Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril. [2005.08]
Incidence and characteristics of angioedema associated with enalapril. [2005.07.25]
Effect of enalapril on left ventricular diameters and exercise capacity in asymptomatic or mildly symptomatic patients with regurgitation secondary to mitral valve prolapse or rheumatic heart disease. [2005.07.01]
Effects of nifedipine GITS 20 mg or enalapril 20 mg on blood pressure and inflammatory markers in patients with mild-moderate hypertension. [2005.07]
Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial. [2005.04]
Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis. [2005.04]
Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus. [2005.04]
Stabilization and regression of albuminuria in Chinese patients with type 2 diabetes: a one-year randomized study of valsartan versus enalapril. [2005.03]
[Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life] [2005.03]
Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study. [2005.02]
Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus. [2005.02]
Enalapril influence on blood pressure and echocardiographic parameters in children with acute postinfectious glomerulonephritis. [2005]
Well-designed clinical trials possibly related to Vasotec (Enalapril)
Beneficial effects of high-dose losartan in IgA nephritis. [2009.06]
Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy. [2009.05]
Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. [2009.05]
Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension. [2009.05]
Prospective change in renal volume and function in children with ADPKD. [2009.04]
Serum phosphorus and cardiovascular mortality in type 2 diabetes. [2009.04]
Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle. [2009.01]
Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension. [2008.12]
Renal effects of aspirin are clearly dose-dependent and are of clinical importance from a dose of 160 mg. [2008.09]
Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure. [2008.08]
Pleiotropic effects of angiotensin-converting enzyme inhibitors in normotensive patients with coronary artery disease. [2008.07]
A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system. [2008.04]
Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. [2008.03]
Renal response to angiotensin II is blunted in sodium-sensitive normotensive men. [2008.03]
Impact of the preintervention rate of renal function decline on outcome of renoprotective intervention. [2008.01]
Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination. [2007.12]
Comparison of high- versus low-tissue affinity ACE-inhibitor treatment on circulating aldosterone levels in patients with chronic heart failure. [2007.12]
Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease. [2007.11]
Mitral insufficiency and morbidity and mortality in left ventricular dysfunction. [2007.08]
Haemorheological disturbances in hypertensive type 2 diabetic patients - influence of antihypertensive therapy. [2007.08]
Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus. [2007.07]
Impact of neurohormonal blockade on association between body mass index and mortality. [2007.06.25]
Dechallenge and rechallenge method showed different incidences of cough among four ACE-Is. [2007.06]
A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy. [2007.04]
Revival of nifedipine, a dihydropyridine-based calcium blocker. [2007]
Indapamide decreases plasma adiponectin concentration in patients with essential hypertension. [2007]
Bisoprolol in the treatment of chronic heart failure. [2007]
Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy. [2007]
Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. [2006.12.05]
The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study. [2006.12]
Effect of angiotensin converting enzyme inhibitors on 1.25-(OH)2 D levels of hypertensive patients. Relationship with ACE polymorphisms. [2006.12]
The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects. [2006.11]
Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients. [2006.09]
Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. [2006.09]
Correlation of flow mediated dilation with inflammatory markers in patients with impaired cardiac function. Beneficial effects of inhibition of ACE. [2006.08]
Angiotensin-converting enzyme inhibitors slow recovery from anemia following cardiac surgery. [2006.07]
Effects of ACE Inhibition and Angiotensin II Receptor Blockade on Glomerular Basement Membrane Protein Excretion and Charge Selectivity in Type 2 Diabetic Patients. [2006.06]
A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination. [2006.05]
The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients. [2006.05]
Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group. [2006.05]
ETa-receptor blockade, but not ACE inhibition, blunts retinal vessel response during isometric exercise. [2006.04]
Changes in aortic stiffness and augmentation index after acute converting enzyme or vasopeptidase inhibition. [2005.11]
Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers. [2005.10]
Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors. [2005.10]
Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction. [2005.10]
|
